Day 1 - Wednesday, 26 June 2019
Meeting category
Date(s)
26 Jun 2019 - 27 Jun 2019
Location
Hong Kong,
China
CME credits
Organizer
Asia-Pacific HIV Clinical Forum 2019
Related Enduring Materials
Enduring Materials
Session 1: Integrase Inhibitors: State of the Art -
Chairs
Patrick Li, MBBS, FHKCP, FHKAM, FRCP, FRCP
Hong Kong Sanatorium and Hospital, Hong Kong SAR, China
Kiat Ruxrungtham, MD
Chulalongkorn University, Thailand
Selected INSTI Highlights - CROI 2019
Barrier to Resistance and Implications for Treatment (No permission for publication)
The Impact of Antiretroviral Drug Resistance in Taiwanese HIV-1-Infected MSM Population Between 2015 and 2018
Trends of Genotypic Sensitivity Scores of HIV-1 in Taiwan: Potential Application in the Selection of Single-Tablet Antiretroviral Regimens
Session 2: Clinical Utility of Integrase Inhibitors -
Chairs
Saye Khoo, MD, PhD
University of Liverpool
Grace Lui, MBChB (Hons), FHKCP, FHKAM
Chinese University of Hong Kong
Clinical Experience INSTI in Japan
Clinical Experience INSTI in Korea (No permission for publication)
Bumsik Chin, MD, PhD
National MEdical Center/Center for Infectious Diseases, Seoul
Clinical Experience INSTI in Thailand
Transmitted Drug Resistance to Integrase Inhibitors is Uncommon in Both Acute and Chronic HIV Infection in Bangkok
Starting PrEP During Acute HIV Infection: What is the Risk for Antiretroviral Drug Resistance?
Dolutegravir Plus Tenofovir Disoproxil Fumarate/ Emtricitabine as HIV Post-Exposure Prophylaxis: Efficacy and Safety Results from Real World Study
Session 3: Drugs to Address Challenging Populations -
Chairs
Jonathan Schapiro, MD
Sheba Medical Center, Israel
Bumsik Chin, MD, PhD
National MEdical Center/Center for Infectious Diseases, Seoul
INSTI Use in Women of Child-Bearing Age - NTD Toxicity
Clinical Utility of INSTIs in Patients with Multiple Co-Morbidities
Jun Chen, MD, PhD
Shanghai Public Health Clinical Center, Shanghai
Challenges in Caring for HIV-TB Coinfected Patients
Clinical Case: HIV/TB Co-Infection (No permission for publication)
Day 2 - Thursday, 27 June 2019
Session 4: Next generation of Antiretroviral Treatment Strategies -
Chairs
Charles Boucher, MD
Erasmus Medical Center, the Netherlands
Shinichi Oka, MD
National Center for Global Health and Medicine, Japan
Reduced Drug Regimens
Update on Long Acting Antiretroviral Drugs
INSTI Research in Asia - What are the Remaining Gaps?
Overview
Welcome
We would like to thank you all for joining us at the Asia-Pacific HIV Clinical Forum: Integrase Inhibitors 2019!
Your excellent questions contributed to the great discussions and ultimate success of this meeting! We would also like to thank our speakers for giving their amazing lectures at these meeting!
Presentation materials have been posted here, provided that speaker's permission was granted.
We would like to encourage you and your colleagues to plan submitting your upcoming research results to the next edition of the meeting.
On behalf of the Asia-Pacific HIV Clinical Forum Program Chairs, we would like to thank ViiV Healthcare for their unrestricted educational grant. We would also like to thank our endorsers for their invaluable support of the meeting.
Background
The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.
Program Chairs
Local Chair
Support
Support
Endorsers
Language
Related Programs
